Solid Tumors Clinical Trials

A listing of Solid Tumors medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 2048 clinical trials
Total Joint Arthroplasty in a Pediatric Population

The primary purpose of this study is to examine the functional ability and quality of life in those patients who received a total joint arthroplasty (TJA) for reasons other than having a solid

  • 12 May, 2022
  • 1 location
French Childhood Cancer Survivor Study

The FCCSS is a multicentric national large-scale collaborative population-based study of children treated for a solid tumor before 2000 in France and before the age of 19 years. The

  • 08 Nov, 2020
Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types

detection of cancer signal in the blood of subjects with solid tumors. The study will include subjects without cancers that will be followed up every 6-months for up to 3-years from blood draw.

Accepts healthy volunteers
  • 16 May, 2022
68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study

-label study, with no control group. Although prostate cancers constitute the usual recommended population for this PET modality, recent evidences suggest that most solid tumors express substantial

  • 19 Apr, 2022
  • 1 location
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body (ON-TRK)

study will enroll adult and paediatric patients suffering from a solid tumor with NTRK gene fusion for whom the decision to treat their disease with VITRAKVI has been made by their treating physicians

  • 10 Aug, 2022
  • 54 locations
Collaborative Registry of Patients With Thyroid Cancer and/or Thyroid Tumors

RATIONALE: This is a registry to gather information about patients with thyroid cancer or thyroid nodules which will facilitate the future study of thyroid nodules and thyroid cancer. There is also an associated biobank with this study for tissue, blood, DNA, and urine. PURPOSE: To develop a Thyroid nodule and …

  • 07 Nov, 2020
  • 1 location
Multidrug Resistance Proteins in Patients Enrolled in Clinical Trials Outside of the National Cancer Institute Center for Cancer Research

RATIONALE: Studying samples of tumor tissue or blood from patients with cancer in the laboratory may help doctors learn more about cancer and the development of multidrug resistance in patients. PURPOSE: This laboratory study is looking at multidrug resistance proteins in patients enrolled in clinical trials outside of the National …

  • 07 Nov, 2020
  • 3 locations
Molecular Characterization of Genetic Alterations in Pediatric Solid Tumors

Background: In Argentina, central nervous system (CNS) solid tumors (19%) and non-CNS solid tumors (25%) account for 44% of pediatric tumors. The new World Health organization (WHO) 2016

  • 04 Mar, 2021
  • 1 location
Registry for Molecular Testing, Treatment and Outcome of Patients With Solid Tumors Harboring a NTRK Gene Fusion

The objective of this registry is to analyze treatment reality and outcome of patients with locally advanced or metastatic solid tumors harboring a fusion of NTRK1, NTRK2 or NTRK3

  • 22 Dec, 2021
  • 10 locations
NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes

Researchers want to learn more about the use of larotrectinib as a real-world treatment for tropomyosin receptor kinase fusion cancer, also called TRK fusion cancer. In people with TRK fusion cancer, a gene called neurotrophic TRK, (NTRK) joins or "fuses" with another gene. This creates a protein known as a …

  • 11 Aug, 2022
  • 1 location